Skip to main content

Editorial Board

Editors-in-Chief

Yasumasa Kato, MedScD, PhD, Ohu University, Japan
New Content Item (1)Research website

ORCID profile
Specialisms: Metastasis, Cancer microenvironment





Andy TY Lau, PhD, Shantou University Medical College, China
New Content ItemResearch website

ORCID profile

Specialisms: Cancer proteomics, Epigenetic toxicology, Epimodifications, Epithelial-mesenchymal plasticity





Associate Editors

Lucie Brisson, PhD, University of Tours, France

New Content Item (1)

Research website

ORCID profile

Specialisms: Tumor microenvironment, Glioblastoma, Metabolism, Autophagy




Ratna Chakrabarti, PhD, University of Central Florida, USA
New Content ItemResearch website

ORCID profile

Twitter: @ChakrabartiR

Specialisms: Noncoding RNA, Regulation of gene expression, Cancer biology, Drug resistance



Gang Chen, PhD, Guangxi Medical University, China

Chenbo Ding, MD, Shanghai Jiao Tong University School of Medicine, China
New Content Item

Research website

ORCID profile

Specialisms: Colorectal cancer, Enteric nervous system, Epigenetic modification, Tumor immunity




Guanxiong Ding, PhD, Huashan hospital, China
New Content Item

Specialisms: Prostate cance







Jesús Espinal-Enríquez, PhD, National Institute of Genomic Medicine, Mexico
New Content Item (1)

Research website

ORCID profile

Twitter: @chuchoEspinal

Specialisms: Cancer genomics, Multi-omics in cancer, Gene co-expression networks, NGS in cancer, Gene regulatory networks


Giuseppe Nicolò Fanelli, MD, PhD, University of Padua, Italy

Giuseppe Fiume, PhD, University of Catanzaro "Magna Graecia", Italy

New Content Item

Research website

ORCID profile

Specialisms: Cell biology, Tumor microenvironment, Immune cells

 




Snehal Gaikwad, PhD, National Cancer Institute, USA
Research websiteNew Content Item

ORCID profile

Specialisms: Cancer biology, Multiple myeloma, Chemoresistance, Molecular imaging, Drug discovery and development





Anjali Geethadevi, PhD, Medical College of Wisconsin, USA

Peeyush Goel, PhD, University of Pennsylvania, USA
New Content Item (1)

Research website

ORCID profile

Specialisms: Breast cancer therapeutics, Bone biology, Osteoclasts, Antibody engineering




Juan Carlos Gómora Martinez, PhD, National Autonomous University of Mexico, Mexico
New Content Item (1)Research website

ORCID profile

Specialisms: Voltage-Gated sodium channels, Beta subunits, Metastasis, Repurposing drugs





Yuchao Jessica Gu, PhD, Stanford University, USA

Atif Hashmi, MD, Liaquat National Hospital and Medical College, Pakistan

Giuseppe Ingravallo, MD, PhD, University of Bari, Italy


Haojie Jin, PhD, Shanghai Cancer Institute, China

New Content Item

Research website

ORCID profile

Specialisms: Oncology, Cancer therapy, Genetic screen, Liver cancer





Goodwin Jinesh, PhD, Moffitt Cancer Center, USA
New Content Item

Research website

ORCID profile

Specialisms: Cancer stem cells, Genomics, Transcriptomics, Epigenetics, Genetics, Immunology, Cell biology, NGS, Oncology, Tumorigenesis, Metastasis




Vivek Kashyap, PhD, University of Texas Rio Grande Valley, USA

Priyanka Khare, PhD, MD Anderson Cancer Center, USA

Ritu Kulshreshtha, PhD, Indian Institute of Technology Delhi, India


Sanjay Kumar, PhD, Sharda University, India
New Content Item (1)

Research website

ORCID profile

Specialisms: Extracellular vesicles (exosomes and microvesicles), Cancer, Kidney disease




Dongjun Lee, PhD, Pusan National University School of Medicine, South Korea
New Content Item

Research website

ORCID profile

Specialisms: Hematological Malignancy, Oncology, Hematology





Yumin Li, PhD, Lanzhou University, China

Chang Liu, PhD, University of Rhode Island, USA
New Content Item (1)

Research website

ORCID profile

Specialisms: Cancer immunotherapy, Immune checkpoints, Proteomics, Natural products




Wenbo Meng, MD, PhD, Lanzhou University, China

Naoshad Muhammad, PhD, Washington University in Saint Louis, USA
New Content Item

Research website

ORCID profile

Specialisms: Cancer Biology, Metabolism, Obesity, Radiation Oncology





Subhadip Mukhopadhyay, PhD, New York University Langone Medical Center, USA

Antonio Giuseppe Naccarato, PhD, University of Pisa, Italy

Aejaz Nasir, MD, MPhil, FCA, Eli Lilly & Company, USA

Tamara Nikuševa-Martić, PhD, University of Zagreb, Croatia

Alessia Nottegar, MD, San Bortolo Hospital of Vicenza, Italy

Nootan Pandey, PhD, University of Pennsylvania, USA


Deepak Parashar, PhD, Medical College of Wisconsin, USA

New Content Item

Research website

ORCID profile

Specialisms: MicroRNA, Cancer Testis Antigens, Angiogenesis, Chemo resistance, Exosomes, Small molecule inhibitors





Junseong Park, PhD, The Catholic University of Korea, South Korea

Jennifer Pasquier, PhD, Breast Cancer Institute - Nice Santa Maria, France

Suja Pillai, PhD, University of Queensland, Australia

New Content Item (1)

Research website

ORCID profile

Specialisms: Colon, Genetics, Endocrine





Agnese Po, PhD, Sapienza University of Rome. Italy

Jin Qian, MD, PhD, Stanford University, USA

New Content Item

Research website

ORCID profile

Specialisms: Cancer treatment resistance, Tumor microenvironment, Ovarian cancer, Gastric cancer




Vinagolu K. Rajasekhar, MPhil, PhD, Memorial Sloan Kettering Cancer Center, USA
New Content Item

Research Website

ORCID profile

Specialisms: Cancer Stem Cells and Patient Tumor Heterogeneity, Immunosuppressive Tumor Microenvironment, Macrophage Plasticity and targeting Adaptive Immune Cell Therapy, Metastatic Clonal Evolution,Humanized PDX Models



Mitsuo Sato, PhD, Nagoya University, Japan
New Content Item

Research website

ORCID profile

Specialisms: Lung cancer, Oncogene, Senescence





Cristian Scatena, MD, PhD, University of Pisa, Italy

New Content Item Research website

 ORCID profile

 Specialisms: Breast cancer, melanoma, molecular pathology, cellular biology





Sahabjada Siddiqui, PhD, Era University, India

New Content Item (1)

Research website

ORCID profile

Specialisms: Natural products, Anticancer and antiosteoporosis biological activities, In silico drug design and development





Atit Silsirivanit, PhD, Khon Kaen University, Thailand
New Content Item

Research website

ORCID profile

Specialisms: Glycosylation, Biomarker, Metastasis, Drug resistance, Glycan, Lectin, Mucin, Glycobiology




Santosh Kumar Singh, PhD, Morehouse School of Medicine, USA
New Content Item (1)

Research website

ORCID profile

Specialisms: Cancer, Drug delivery, Drug resistance, Targeted therapy, Combination therapy, Chemokines

 



Ichidai Tanaka, MD, Nagoya University, Japan

New Content Item

Research website

ORCID profile

Specialisms: Lung cancer, Mesothelioma, Molecular biology, Cell culture 





Andrey Turchinovich, PhD, MBA, German Cancer Research Center, Germany

Franco Vizeacoumar, PhD, University of Saskatchewan, Canada

New Content Item (1)Research website

ORCID profile

Specialisms: Cancer genomics, Telomerase, Polo-like kinase, TERRA, CRISPR/Cas9 screens, Genome instability, DNA repair





Amy Yan-Ming Xu, PhD, Shantou University Medical College, China

New Content Item

Research website

ORCID profile

Specialisms: Cancer biology, Therapeutics, Natural compounds, Nutriepigenetics





Pei-Ming Yang, PhD, Taipei Medical University, Taiwan
New Content Item (1)

Research website

ORCID profile

Specialisms: Cancer biology, Autophagy, Cancer therapeutics, Drug resistance, Drug repurposing




Ling Zhang, MD, Moffitt Cancer Institute, USA
New Content Item

Research website

ORCID profile

Specialisms: Hematology





Ying Zou, MD, PhD, Johns Hopkins University, USA
New Content Item

Research website

ORCID profile

Specialisms: Cancer Genetics, Next generation sequencing, Mutations, Solid tumors, Leukemia/lymphoma, Telomere




Editorial Board
Elena Adinolfi, MD, PhD, University of Ferrara, Italy
Faisal Aziz, PhD, University of Minnesota, USA
Michele Caraglia, MD, PhD, Second University of Naples, Italy 
Rosa A Cardone, PhD, University of Bari, Italy
Wenbin Chen, PhD, Zhejiang University School of Medicine, China
Zhijian Duan, PhD, University of California Davis, USA
Yi Hu, PhD, Shengjing Hospital of China Medical Univ., China and Univ. of California San Diego, USA*
Tim Illidge, PhD, FRCP, FRCR, FRCPath, The University of Manchester, UK
Ruy Jaeger, DDS, PhD, University of Sao Paulo, Brazil 
Xiaohua Jiang, PhD, The Chinese University of Hong Kong, Hong Kong
Manoj Kashyap, PhD, Amity University Haryana, India 
Khandan Keyomarsi, PhD, MD Anderson Cancer Center, USA
Sajid Khan, PhD, University of Florida, USA
Vinod Kumar, PhD, University of Pittsburgh, USA
Mokenge Malafa, MD, Moffitt Cancer Center, USA
Parvin Mehdipour, PhD, Tehran University of Medical Sciences, Iran
Javier A Menendez, PhD, Catalan Institute of Oncology (ICO) and Girona Biomedical Research Institute (IDIBGI)Spain
Sritama Nath, PhD, MedThink Communications, USA
Athanasios G. Papavassiliou, MD, PhD, National and Kapodistrian University of Athens, Greece
Nives Pećina-Šlaus, MD, University of Zagreb, Croatia
Geoffrey Pilkington, PhD, FIScT, FRSB, FRCPath, University of Portsmouth, UK 
Tao Ren, MD, PhD, Shanghai Jiao Tong University, China
Carlos Sonnenschein, MD, Tufts University School of Medicine, USA
Christian Stock, PhD, Hannover Medical School, Germany
Carlos Telleria, PhD, McGill University, Canada
Koraljka Gall Trošelj, PhD, Ruđer Bošković Institute, Croatia
Sivakumar Vallabhapurapu, PhD, Indian Institute of Science Education and Research - Tirupati, India
Go J. Yoshida, MD, PhD, Tokyo Medical and Dental University, Japan

Trusted Reviewers
Raziyeh Abooshahab, PhD, Curtin University, Australia
Imran Ahmad , PhD, King George's Medical University, India
Rosario Avolio, PhD, University of Naples Federico II, Italy
Nabamita Boruah, PhD, North Eastern Hill University, India
Yanyang Cao, PhD, Ohio University, United States
Alessandro Cavaliere, MD, University of Turin, Italy 
Ankita Chatterjee, PhD, National Institute of Biomedical Genomics, India
Shan-Shan Cheng, PhD, Tongji University, China
Laetitia Collet, MD, Institut Jules Bordet, Belgium
Charlotte M Degorre, PhD, National Cancer Institute, United States
Nilambra Dogra, PhD, Panjab University, India
Yongfei He, PhD, The Eighth Affiliated Hospital of Sun Yat-sen University, China
Muzammal Hussain, PhD, New York University Grossman School of Medicine, United States
Mohit Jadli, PhD, University of Delhi, India
Qi Jia, PhD, Shanghai Cancer Institute, China
Tariq Nadeem, PhD, University of the Punjab, Pakistan
Priya Ramanathan, PhD, Cancer Institute (W.I.A.), India
Khurram Rehman, PhD, Gomal University, Pakistan
Snigdha Saikia, PhD, Gauhati University, India
Jorge Sandoval-Basilio, PhD, Universidad Hipócrates, Mexico
Real Sumayya Abdul Sattar, PhD, University of Delhi, India
Kazumasa Sekihara, PhD, Kanagawa Prefectural Hospital Organization, Japan
Igor A Sherman, PhD, Alpha Cancer Technologies, Canada
Bo Sun, PhD, Wuhan Union Hospital, China
Kulbhushan Thakur, PhD, University of Delhi, India
Alfredo Toledo-Leyva, PhD, Instituto Nacional de Cancerología, Mexico
Mansoor-Ali Vaali-Mohammed, PhD, King Saud University, Saudi Arabi

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 5.3
    5-year Journal Impact Factor: 5.0
    Source Normalized Impact per Paper (SNIP): 0.920
    SCImago Journal Rank (SJR): 1.257

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 110

    Usage 2023
    Downloads: 2,067,719
    Altmetric mentions: 1,052

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here